Metabolic & Weight Research

RETATRUTIDE

Research Use Only
Purity
99%
CAS Number
2381089-83-2
Molecular Weight
Approximately 4,731.33 g/mol
Storage
2–8°C (36–46°F)
Zurich Rx research vial with red cap
RETATRUTIDE

Compound Overview

Retatrutide is a synthetic 39-amino acid peptide engineered as a triple receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP) receptor, glucagon-like peptide-1 (GLP-1) receptor, and glucagon receptor (GCGR). The peptide has been designed to investigate the combined effects of incretin biology and glucagon receptor signaling within a single molecular entity. Owing to its multi-receptor pharmacology, Retatrutide has become an important investigational peptide in metabolic physiology, endocrinology, and peptide pharmacology research.

Researchers have studied Retatrutide in experimental models involving energy metabolism, glucose homeostasis, receptor pharmacology, appetite regulation, hepatic metabolism, and lipid biology. Its unique mechanism allows investigators to examine coordinated signaling across three distinct G protein-coupled receptors (GPCRs), providing valuable insight into integrated metabolic regulation and receptor interactions. Retatrutide remains an investigational peptide and has not been approved for general clinical use.

As an investigational peptide, Retatrutide supports laboratory research involving metabolic biology, endocrinology, molecular pharmacology, receptor signaling, and structure-activity relationship studies.

Research Applications

GLP-1 receptor signaling GIP receptor pharmacology Glucagon receptor biology Energy metabolism Glucose homeostasis Lipid metabolism Endocrine physiology Appetite regulation Structure-activity relationship (SAR) investigations Animal model research

Research applications are presented for educational and informational purposes only and do not imply approved therapeutic uses.

Product Specifications

Purity99%
AppearanceWhite to Off-White Lyophilized Powder
Sequence39-amino acid synthetic peptide (proprietary modified sequence)
Molecular FormulaC221H342N46O68
Molecular WeightApproximately 4,731.33 g/mol
CAS Number2381089-83-2
StorageStore refrigerated at 2–8°C (36–46°F). For extended laboratory storage, maintain at −20°C or below. Protect from moisture and light.
Research GradeLaboratory Research Use Only

Available Sizes

10 mg 20 mg 40 mg 50 mg 60 mg

Pricing: Inquire — contact our team for current pricing and availability.

Product Documentation

COA
HPLC Report
Mass Spec
Purity Data
Request documentation for your exact lot

Every batch of RETATRUTIDE is independently tested and assigned its own lot number. When you request documentation, include the product name and lot number printed on your vial so we can send the COA, HPLC, and MS data specific to the batch in your hand — not a generic reference sample. Request documentation →

Laboratory Handling

Store refrigerated immediately upon receipt to preserve peptide stability. For extended laboratory storage, freezing at −20°C or below is recommended. Protect the lyophilized peptide from moisture, excessive heat, and direct light. Following reconstitution, avoid repeated freeze-thaw cycles, as these may reduce peptide stability and biological integrity. Allow the vial to equilibrate to room temperature before opening to minimize condensation, and always use sterile laboratory equipment together with appropriate aseptic laboratory techniques. This product is intended for use only by qualified research personnel operating in controlled laboratory environments.

Selected Scientific Literature

  1. Coskun T, Urva S, Roell WC, et al. LY3437943, a Novel Triple GIP, GLP-1, and Glucagon Receptor Agonist for the Treatment of Metabolic Disease. Cell Metabolism.
  2. Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine.
  3. Müller TD, Finan B, Clemmensen C, et al. The New Biology and Pharmacology of Glucagon. Physiological Reviews.
  4. Campbell JE, Drucker DJ. Islet α Cells and Glucagon—Critical Regulators of Energy Homeostasis. Nature Reviews Endocrinology.
Research Use Only (RUO)

This product is intended exclusively for laboratory research. It is not intended for human consumption, therapeutic use, diagnostic procedures, or veterinary applications. Zurich Rx supplies research materials solely for scientific investigation; researchers are responsible for ensuring products are handled and used in accordance with applicable laws and institutional policies. See our full RUO disclaimer.

Compare with related compounds

Other compounds researchers commonly browse alongside RETATRUTIDE in Metabolic & Weight Research.

CompoundPurityMolecular WeightCAS Number
RETATRUTIDE99%Approximately 4,731.33 g/mol2381089-83-2
AOD-960499%1,815.08 g/mol221231-10-3
CAGRILINTIDE99%Approximately 4,183.8 g/mol1415456-99-3
MAZDUTIDE99%Approximately 4.5 kDaNot Assigned
SURVODUTIDE99%Approximately 4.6 kDaNot Assigned

Need a Certificate of Analysis?

Request COAs, HPLC, or MS documentation for RETATRUTIDE.

Request Pricing